Add to ORKGbution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. There is some published evidence suggesting micro vascular endothelial dysfunction and dysautonomia involvement in Chagas disease in association with cardiomyocyte changes favoring disease progression. The combined treatment between angiotensin con-verting enzyme (ACE) inhibitor drugs; Simvastatin, muscarinic antibody immunoadsorbent together with fungicidal drugs would open therapeutic possibilities in this disease
There is ample experimental and clinical evidence of functional and structural microvascular abnorma...
Chagas disease is an infectious disease caused by Trypanosoma cruzy, this is a highly frequent disea...
<div><p>Abstract Chronic Chagas disease cardiomyopathy (CCC) is a result of low-intensity, but inces...
BackgroundCardiac complications, including heart failure and arrhythmias, are the leading causes of ...
Artículo de publicación ISIChronic Chagas’ disease affects 10–30 % of patients infected with Trypan...
Chagas' disease, caused by Trypanosoma cruzi infection, is ranked as the most serious parasitic dise...
Chagas disease is a parasitic infection caused by the intracellular protozoan Trypanosoma cruzi. Chr...
Chagas cardiomyopathy is the most frequent and most severe manifestation of chronic Chagas disease, ...
Chronic chagasic cardiomyopathy affects 20% of Chagas disease patients. At present, Chagas disease c...
ABSTRACTBACKGROUNDThere is evidence based on experimental models studies in infections by Trypanosom...
Trypanosoma cruzi infection induces progressive cardiac inflammation that leads to fibrosis and modi...
Nearly a century after its discovery, Chagas' disease, caused by the protozoan Trypanosoma cruzi, re...
Current treatments for chronic Chagas cardiomyopathy, a disease with high mortality rates and cause...
© 2015 Campos-Estrada et al.Trypanosoma cruzi is the causal agent of Chagas Disease that is endemic ...
Chronic Heart Failure affects about half patients with Chagas cardiomyopathy. Poor outcomes of CHF s...
There is ample experimental and clinical evidence of functional and structural microvascular abnorma...
Chagas disease is an infectious disease caused by Trypanosoma cruzy, this is a highly frequent disea...
<div><p>Abstract Chronic Chagas disease cardiomyopathy (CCC) is a result of low-intensity, but inces...
BackgroundCardiac complications, including heart failure and arrhythmias, are the leading causes of ...
Artículo de publicación ISIChronic Chagas’ disease affects 10–30 % of patients infected with Trypan...
Chagas' disease, caused by Trypanosoma cruzi infection, is ranked as the most serious parasitic dise...
Chagas disease is a parasitic infection caused by the intracellular protozoan Trypanosoma cruzi. Chr...
Chagas cardiomyopathy is the most frequent and most severe manifestation of chronic Chagas disease, ...
Chronic chagasic cardiomyopathy affects 20% of Chagas disease patients. At present, Chagas disease c...
ABSTRACTBACKGROUNDThere is evidence based on experimental models studies in infections by Trypanosom...
Trypanosoma cruzi infection induces progressive cardiac inflammation that leads to fibrosis and modi...
Nearly a century after its discovery, Chagas' disease, caused by the protozoan Trypanosoma cruzi, re...
Current treatments for chronic Chagas cardiomyopathy, a disease with high mortality rates and cause...
© 2015 Campos-Estrada et al.Trypanosoma cruzi is the causal agent of Chagas Disease that is endemic ...
Chronic Heart Failure affects about half patients with Chagas cardiomyopathy. Poor outcomes of CHF s...
There is ample experimental and clinical evidence of functional and structural microvascular abnorma...
Chagas disease is an infectious disease caused by Trypanosoma cruzy, this is a highly frequent disea...
<div><p>Abstract Chronic Chagas disease cardiomyopathy (CCC) is a result of low-intensity, but inces...